Secondary CIC‑rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report-Reference-Cited by-同舟云学术

Secondary CIC‑rearranged sarcoma responsive to chemotherapy regimens for Ewing sarcoma: A case report

Published:2021-02-08 Issue:4 Volume:14 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Kimbara Shiro¹,Imamura Yoshinori¹,Kiyota Naomi¹,Takakura Hidetomo¹,Matsumoto Sakuya¹,Koyama Taiji¹,Fujishima Yoshimi¹,Funakoshi Yohei¹,Toyoda Masanori¹,Hirose Takanori²,Kanzawa Maki²,Kawamoto Teruya³,Hara Hitomi³,Minami Hironobu¹

Affiliation:

1. Department of Medical Oncology/Hematology, Kobe University Hospital, Kobe, Hyogo 650‑0017, Japan

2. Department of Diagnostic Pathology, Kobe University Hospital, Kobe, Hyogo 650‑0017, Japan

3. Department of Orthopaedic Surgery, Kobe University Hospital, Kobe, Hyogo 650‑0017, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility and Toxicity of Interval-Compressed Chemotherapy in Asian Children and Young Adults with Sarcoma;Journal of Personalized Medicine;2023-04-14

2. Update of pediatric bone tumors—other mesenchymal tumors of bone, hematopoietic neoplasms of bone, and WHO classification of undifferentiated small round cell sarcomas of bone;Skeletal Radiology;2023-01-19

3. Systemic treatments and outcomes in CIC ‐rearranged Sarcoma: A national multi‐centre clinicopathological series and literature review;Cancer Medicine;2022-02-17

4. Doxorubicin/etoposide/ifosfamide;Reactions Weekly;2021-05